Cargando…
Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675997/ https://www.ncbi.nlm.nih.gov/pubmed/36415602 http://dx.doi.org/10.2147/OPTH.S379373 |
_version_ | 1784833494044639232 |
---|---|
author | Moleiro, Ana Filipa Godinho, Gonçalo Madeira, Carolina Faria Pereira, Ana Brandão, Elisete Falcão-Reis, Fernando Beato, João Nuno Penas, Susana |
author_facet | Moleiro, Ana Filipa Godinho, Gonçalo Madeira, Carolina Faria Pereira, Ana Brandão, Elisete Falcão-Reis, Fernando Beato, João Nuno Penas, Susana |
author_sort | Moleiro, Ana Filipa |
collection | PubMed |
description | PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerve fiber layer thickness (pRNFL). PATIENTS AND METHODS: This was a retrospective longitudinal study of 71 eyes from 71 patients with treatment-naïve retinal vein occlusion (24 CRVO and 40 BRVO). Spectral-domain optical coherence tomography (SD-OCT, Spectralis HRA-OCT, Heidelberg) was used to measure PPCT, SFCT, pRNFL and CMT of the affected and fellow eyes at baseline (acute phase) and at 3 and 9 months post anti-VEGF treatment. IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. A p-value ≤0.05 was considered statistically significant. RESULTS: Affected eyes presented a thicker baseline PPCT and SFCT compared to their fellow eyes both in CRVO and BRVO (p < 0.05). Both groups presented a significant decrease of PPCT in the affected eyes at 3 months compared to baseline (p < 0.05). At 9 months, compared to 3 months, PPCT remained stable (p > 0.05). Similarly, affected eyes’ SFCT significantly decreased at 3 months (p < 0.05) in both groups. At 9 months, compared to 3 months, SFCT decreased in the CRVO patients (p = 0.047) but remained stable in the BRVO patients (p = 0.850). No correIations between SFCT and CMT were seen at any timepoint in both groups (p > 0.05). PPCT correlates with pRNFL in CRVO at 3 months, although no other correlations were found during the follow-up. In BRVO, PPCT did not show any significant correlation with pRNFL. CONCLUSION: Both in CRVO and BRVO eyes, PPCT and SFCT at diagnosis are significantly thicker compared to the fellow eye, suggesting a possible increase in CT immediately after the occlusion, which is followed by a decrease at an early follow-up stage. |
format | Online Article Text |
id | pubmed-9675997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-96759972022-11-21 Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions Moleiro, Ana Filipa Godinho, Gonçalo Madeira, Carolina Faria Pereira, Ana Brandão, Elisete Falcão-Reis, Fernando Beato, João Nuno Penas, Susana Clin Ophthalmol Original Research PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerve fiber layer thickness (pRNFL). PATIENTS AND METHODS: This was a retrospective longitudinal study of 71 eyes from 71 patients with treatment-naïve retinal vein occlusion (24 CRVO and 40 BRVO). Spectral-domain optical coherence tomography (SD-OCT, Spectralis HRA-OCT, Heidelberg) was used to measure PPCT, SFCT, pRNFL and CMT of the affected and fellow eyes at baseline (acute phase) and at 3 and 9 months post anti-VEGF treatment. IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. A p-value ≤0.05 was considered statistically significant. RESULTS: Affected eyes presented a thicker baseline PPCT and SFCT compared to their fellow eyes both in CRVO and BRVO (p < 0.05). Both groups presented a significant decrease of PPCT in the affected eyes at 3 months compared to baseline (p < 0.05). At 9 months, compared to 3 months, PPCT remained stable (p > 0.05). Similarly, affected eyes’ SFCT significantly decreased at 3 months (p < 0.05) in both groups. At 9 months, compared to 3 months, SFCT decreased in the CRVO patients (p = 0.047) but remained stable in the BRVO patients (p = 0.850). No correIations between SFCT and CMT were seen at any timepoint in both groups (p > 0.05). PPCT correlates with pRNFL in CRVO at 3 months, although no other correlations were found during the follow-up. In BRVO, PPCT did not show any significant correlation with pRNFL. CONCLUSION: Both in CRVO and BRVO eyes, PPCT and SFCT at diagnosis are significantly thicker compared to the fellow eye, suggesting a possible increase in CT immediately after the occlusion, which is followed by a decrease at an early follow-up stage. Dove 2022-11-16 /pmc/articles/PMC9675997/ /pubmed/36415602 http://dx.doi.org/10.2147/OPTH.S379373 Text en © 2022 Moleiro et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Moleiro, Ana Filipa Godinho, Gonçalo Madeira, Carolina Faria Pereira, Ana Brandão, Elisete Falcão-Reis, Fernando Beato, João Nuno Penas, Susana Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title | Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title_full | Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title_fullStr | Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title_full_unstemmed | Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title_short | Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions |
title_sort | peripapillary and subfoveal choroidal thickness in retinal vein occlusions |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675997/ https://www.ncbi.nlm.nih.gov/pubmed/36415602 http://dx.doi.org/10.2147/OPTH.S379373 |
work_keys_str_mv | AT moleiroanafilipa peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT godinhogoncalo peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT madeiracarolina peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT fariapereiraana peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT brandaoelisete peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT falcaoreisfernando peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT beatojoaonuno peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions AT penassusana peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions |